DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-10.64%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.35B
AUM Growth
+$2.35B
(-1.2%)
Cap. Flow
+$239M
Cap. Flow
% of AUM
10.19%
Top 10 Holdings %
Top 10 Hldgs %
36.4%
Holding
126
New
15
Increased
30
Reduced
16
Closed
18
Top Buys
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$60.9M |
| 2 |
Editas Medicine
EDIT
|
$59M |
| 3 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$49.1M |
| 4 |
Viatris
VTRS
|
$36M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$34.1M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$84.3M |
| 2 |
Teva Pharmaceuticals
TEVA
|
$53.5M |
| 3 |
Charles River Laboratories
CRL
|
$30.3M |
| 4 |
GHDX
Genomic Health, Inc.
GHDX
|
$28.5M |
| 5 |
Pacira BioSciences
PCRX
|
$28.5M |
Sector Composition
| 1 | Healthcare | 69.81% |
| 2 | Financials | 4.2% |
| 3 | Technology | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $228M | 9.69% | 13,740,261 +2,055,460 | +18% | +$34.1M |
|
|
2
Viatris
VTRS
$12.3B
| $84.9M | 3.62% | 1,832,535 +776,535 | +74% | +$36M |
|
|
NXTM
3
DELISTED
NxStage Medical Inc.
NXTM
| $82.5M | 3.51% | 5,506,028 +917,028 | +20% | +$13.7M |
|
4
GSK
GSK
$79.9B
| $67.9M | 2.89% | 1,675,385 | – | – |
|
|
AET
5
DELISTED
Aetna Inc
AET
| $66.5M | 2.83% | 591,465 | – | – |
|
|
PTLA
6
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $63M | 2.68% | 3,089,785 +2,406,036 | +352% | +$49.1M |
|
|
AVXS
7
DELISTED
AveXis, Inc. Common Stock
AVXS
| $60.9M | 2.59% | +2,236,701 | New | +$60.9M |
|
8
DaVita
DVA
$9.85B
| $60.3M | 2.57% | 822,000 | – | – |
|
|
9
Editas Medicine
EDIT
$231M
| $59M | 2.51% | +1,709,400 | New | +$59M |
|
|
ADPT
10
DELISTED
Adeptus Health Inc.
ADPT
| $53.1M | 2.26% | 956,533 -351,375 | -27% | -$19.5M |
|
|
XNPT
11
DELISTED
XENOPORT, INC.
XNPT
| $52.2M | 2.22% | 11,572,125 +5,284,751 | +84% | +$23.8M |
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $50.1M | 2.13% | 5,996,691 | – | – |
|
|
GWPH
13
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $48.7M | 2.07% | 674,373 +364,251 | +117% | +$26.3M |
|
14
Xencor
XNCR
$580M
| $46.5M | 1.98% | 3,467,512 +2,210,900 | +176% | +$29.7M |
|
|
AAC
15
DELISTED
AAC Holdings, Inc.
AAC
| $45.4M | 1.93% | 2,294,936 +512,842 | +29% | +$10.1M |
|
|
AVDL
16
Avadel Pharmaceuticals
AVDL
$1.43B
| $45M | 1.91% | 4,072,809 | – | – |
|
|
WBA
17
DELISTED
Walgreens Boots Alliance
WBA
| $43.1M | 1.83% | 511,457 +125,000 | +32% | +$10.5M |
|
|
UAM
18
DELISTED
Universal American Corp
UAM
| $37.7M | 1.61% | 5,285,500 +496,473 | +10% | +$3.54M |
|
|
SAGE
19
DELISTED
Sage Therapeutics
SAGE
| $35.7M | 1.52% | 1,113,654 +514,800 | +86% | +$16.5M |
|
|
AERI
20
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $32M | 1.36% | 2,632,482 +1,824,607 | +226% | +$22.2M |
|
21
eHealth
EHTH
$118M
| $30.7M | 1.31% | 3,264,588 | – | – |
|
|
ZLTQ
22
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $30M | 1.28% | +1,104,417 | New | +$30M |
|
|
ARRY
23
DELISTED
Array Biopharma Inc
ARRY
| $28.1M | 1.2% | 9,529,361 +800,000 | +9% | +$2.36M |
|
|
FPRX
24
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $27.6M | 1.18% | 680,000 | – | – |
|
25
McKesson
MCK
$85.4B
| $27.5M | 1.17% | 175,000 +30,354 | +21% | +$4.77M |
|